Risiken in der ArzneimitteltherapieWas müssen Patientinnen und Patienten wissen? Was können sie tun?*Risks Associated with Drug Therapy. What Do Patients Need to Know? What Can They Do?

被引:0
作者
Edgar A. Mueller
Wilhelm Kirch
机构
[1] Medizinische Fakultät,Institut für Klinische Pharmakologie
[2] Technische Universität,Institut für Klinische Pharmakologie
[3] Medizinische Fakultät Technische Universität Dresden,undefined
来源
Medizinische Klinik | 2009年 / 104卷
关键词
Arzneimitteltherapie; Deutschland; Medikationsfehler; Risiken; Unerwünschtes Arzneimittelereignis; Adverse drug event; Drug therapy; Germany; Medication error; Risks;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:846 / 850
页数:4
相关论文
共 45 条
[1]  
Mueller E.A.(2006)Efficacy and safety of the six-dose regimen of artemether-lumefantrine for treatment of uncomplicated Acta Trop 100 41-53
[2]  
van Vugt M.(2008) malaria in adolescents and adults: a pooled analysis of individual patient data from randomized clinical trials Med Klin 103 712-716
[3]  
Kirch W.(1990)Kosten-Nutzen-Bewertung von Arzneimitteln: Fachübergreifende Zusammenarbeit und Transparenz sind entscheidend J Intern Med 228 83-90
[4]  
Mueller E.A.(1992)Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention Br J Clin Pharmacol 33 61-68
[5]  
Kirch W.(2002)Drug related admissions to medical wards: a population based survey Eur J Clin Pharmacol 58 285-291
[6]  
Hallas J.(2004)Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study J Intern Med 255 653-663
[7]  
Harvald B.(2009)Readmissions and adverse drug reactions in internal medicine: the economic impact BMC Clin Pharmacol 9 8-274
[8]  
Gram L.F.(2009)The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty Intensive Care Med 35 266-86
[9]  
Hallas J.(1999)Adverse drug reactions and deliberate self-poisoning as cause of admission to the intensive care unit: a 1-year prospective observational cohort study Arzneimitteltherapie 17 83-16
[10]  
Gram L.F.(2000)Klinik-basierte Erfassung Arzneimittel-bedingter Erkrankungen im Pharmakovigilanz-System (ZKH Bremen) Rhein Ärztebl 8 15-895